| Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE database |
|
Blood Cancer Journal |
Myelodysplastic Syndromes (MDS) |
| Immunological links between aplastic anemia and paroxysmal nocturnal hemoglobinuria |
|
International Journal of Hematology |
Aplastic Anemia |
| Iptacopan monotherapy resulted in increased hemoglobin level in patients with PNH and hemoglobin ≥10 g/dL after anti-C5 therapy |
|
HemaSphere |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
| Iptacopan monotherapy resulted in increased hemoglobin level in patients with PNH and hemoglobin ≥10 g/dL after anti-C5 therapy |
|
HemaSphere |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
| A Survey of Provider Practices for Diagnosis and Treatment of Pediatric Moderate Aplastic Anemia From the North American Pediatric Aplastic Anemia Consortium |
|
Journal of Pediatric Hematology/Oncology (JPHO) |
Aplastic Anemia |
| Clonal Dynamics of Hematopoiesis in Aplastic Anemia after Immunosuppression and Eltrombopag |
|
The New England Journal of Medicine |
Aplastic Anemia |
| Clonal Selection and Evolution after Treatment of Severe Aplastic Anemia |
|
The New England Journal of Medicine |
Aplastic Anemia |
| High-resolution single-cell mapping of clonal hematopoiesis and structural variation in aplastic anemia |
|
Nature Genetics |
Aplastic Anemia |
| Clonal Hematopoiesis Diversity in Aplastic Anemia - When Does It Matter Clinically? |
|
The New England Journal of Medicine |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
| Real-World Effectiveness and Safety of Ravulizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria: Evidence From the International PNH Registry |
|
American Journal of Hematology |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
